MIRM

41.51

0.92% 0.38

시간 외 거래: 41.50 -0.010 -0.02%

Mirum Pharmaceuticals Inc (MIRM)

개요 뉴스 가격 이력 옵션 체인 Financials MIRM 왜 하락? 토론 예측

전일 마감가:

$41.13

열려 있는:

$40.58

하루 거래량:

1.15M

Relative Volume:

3.09

시가총액:

$1.99B

수익:

$264.38M

순이익/손실:

$-109.16M

주가수익비율:

-9.6629

EPS:

-4.2958

순현금흐름:

$-39.22M

1주 성능:

-2.19%

1개월 성능:

-4.99%

6개월 성능:

+33.30%

1년 성능:

+34.82%

1일 변동 폭

$40.58

$42.85

1주일 범위

$40.03

$43.37

52주 변동 폭

$23.14

$48.89

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

명칭

Mirum Pharmaceuticals Inc

부문

Healthcare (1176)

산업

Biotechnology (673)

전화

650-667-4085

주소

989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY

직원

311

트위터

@mirumpharma

다음 수익 날짜

2024-11-04

최신 SEC 제출 서류

MIRM's Discussions on Twitter

MIRM을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
MIRM Mirum Pharmaceuticals Inc	41.51	1.99B	264.38M	-109.16M	-39.22M	-2.3395
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-04-17	개시	Stifel	Buy
2023-12-18	재확인	H.C. Wainwright	Buy
2023-11-20	재개	JP Morgan	Overweight
2023-11-13	개시	Morgan Stanley	Overweight
2023-10-24	개시	Cantor Fitzgerald	Overweight
2023-10-17	재개	Evercore ISI	Outperform
2023-09-20	개시	JMP Securities	Mkt Outperform
2022-09-01	개시	Citigroup	Buy
2021-09-20	개시	JP Morgan	Overweight
2020-08-07	업그레이드	Raymond James	Outperform → Strong Buy
2020-08-03	개시	H.C. Wainwright	Buy
2020-07-31	개시	Piper Sandler	Overweight
2020-06-25	개시	Robert W. Baird	Outperform
2019-08-12	개시	Citigroup	Buy
2019-08-12	개시	Evercore ISI	Outperform
2019-08-12	개시	Guggenheim	Buy
2019-08-12	개시	ROTH Capital	Buy
2019-08-12	개시	Raymond James	Outperform

모두보기

Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스

Dec 18, 2024

State Street Corp Buys 297,511 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 18, 2024

Dec 17, 2024

Mirum Pharmaceuticals' SWOT analysis: liver disease specialist's stock poised for growth - Investing.com

Dec 17, 2024

Wellington Management Group LLP Has $4.77 Million Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 17, 2024

Dec 16, 2024

741,368 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Bought by Lord Abbett & CO. LLC - MarketBeat

Dec 16, 2024

Mirum Pharmaceuticals and GC Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Liver Diseases in South Korea - Marketscreener.com

Dec 16, 2024

Dec 15, 2024

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Target Price at $57.73 - MarketBeat

Dec 15, 2024

Dec 12, 2024

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report? - MSN

Dec 12, 2024

Dec 11, 2024

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 10, 2024 - BioSpace

Dec 11, 2024

Dec 10, 2024

Frazier Life Sciences Management L.P. Purchases 75,000 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 10, 2024

Mirum Pharmaceuticals Awards Key Inducement Grants to Strengthen Leadership Team - StockTitan

Dec 10, 2024

Dec 09, 2024

Investors Aren't Buying Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Revenues - Simply Wall St

Dec 09, 2024

Charles Schwab Investment Management Inc. Acquires 17,149 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 09, 2024

Dec 06, 2024

Mirum Pharmaceuticals price target raised to $74 from $69 at JMP Securities - Yahoo Finance

Dec 06, 2024

Dec 05, 2024

(MIRM) Trading Advice - Stock Traders Daily

Dec 05, 2024

Dec 04, 2024

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by Janus Henderson Group PLC - MarketBeat

Dec 04, 2024

Dec 02, 2024

Mirum Shares Surge More Than 90% in 6 Months: Here's Why - MSN

Dec 02, 2024

Erste Asset Management GmbH Buys Shares of 260,000 Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 02, 2024

Intech Investment Management LLC Takes Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 02, 2024

Nov 30, 2024

Eventide Asset Management LLC Sells 1,119,457 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Nov 30, 2024

Nov 27, 2024

Loomis Sayles & Co. L P Buys New Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Nov 27, 2024

Nov 25, 2024

Connor Clark & Lunn Investment Management Ltd. Acquires 21,526 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Nov 25, 2024

Nov 24, 2024

(MIRM) Technical Data - Stock Traders Daily

Nov 24, 2024

Nov 23, 2024

Mirum Pharmaceuticals success with study of drug for chronic liver disease - OutSourcing-Pharma.com

Nov 23, 2024

Nov 20, 2024

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised - MSN

Nov 20, 2024

Phocas Financial Corp. Cuts Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Nov 20, 2024

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $57.73 - MarketBeat

Nov 20, 2024

Nov 19, 2024

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Position Decreased by First Turn Management LLC - MarketBeat

Nov 19, 2024

Nov 18, 2024

Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Down 4.6% After Insider Selling - MarketBeat

Nov 18, 2024

Cantor Fitzgerald Analysts Raise Earnings Estimates for MIRM - MarketBeat

Nov 18, 2024

Nov 16, 2024

Insider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) SVP Sells 2,500 Shares of Stock - MarketBeat

Nov 16, 2024

Nov 15, 2024

Mirum Pharmaceuticals SVP sells $117,752 in stock - Investing.com

Nov 15, 2024